These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23257692)

  • 1. Physiological imaging-defined, response-driven subvolumes of a tumor.
    Farjam R; Tsien CI; Feng FY; Gomez-Hassan D; Hayman JA; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1383-90. PubMed ID: 23257692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy.
    Farjam R; Tsien CI; Lawrence TS; Cao Y
    Med Phys; 2014 Jan; 41(1):011708. PubMed ID: 24387500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.
    Wang P; Popovtzer A; Eisbruch A; Cao Y
    Med Phys; 2012 Aug; 39(8):5277-85. PubMed ID: 22894453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
    Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial perfusion imaging-defined subvolume of intrahepatic cancer.
    Wang H; Farjam R; Feng M; Hussain H; Ten Haken RK; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):167-74. PubMed ID: 24613814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
    Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy.
    Lagerwaard FJ; van der Hoorn EA; Verbakel WF; Haasbeek CJ; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):253-9. PubMed ID: 19577856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
    Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
    J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy.
    Teng F; Tsien CI; Lawrence TS; Cao Y
    Radiother Oncol; 2017 Oct; 125(1):89-93. PubMed ID: 28835339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?
    Vidiri A; Guerrisi A; Pinzi V; Fabi A; Mirri MA; Pompili A; Caporale N; Pace A; Crecco M; Marzi S
    Eur J Radiol; 2012 Jun; 81(6):1246-52. PubMed ID: 21458183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected].
    Cao Y; Tsien CI; Nagesh V; Junck L; Ten Haken R; Ross BD; Chenevert TL; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):876-85. PubMed ID: 16298499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
    Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
    Yuen AHL; Wu PM; Li AKL; Mak PCY
    Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.
    Farjam R; Tsien CI; Feng FY; Gomez-Hassan D; Hayman JA; Lawrence TS; Cao Y
    Neuro Oncol; 2014 Jan; 16(1):131-9. PubMed ID: 24327584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.